Source: Eur Respir Monogr 2022; 96: 316-327



Rating:

Share or cite this content

Citations should be made in the following way:
Daniel A. Culver, Athol U. Wells. When to treat sarcoidosis. Eur Respir Monogr 2022; 96: 316-327

Member's Comments

No comment yet.

Related content which might interest you: Extrapulmonary sarcoidosis: what to look for and how to treat Source: International Congress 2019 – State of the art session: Interstitial lung diseases Year: 2019 How to treat bronchial granuloma in chronic granulomatous disease? Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Pneumonia-like sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 233s Year: 2003 How to recognise and what to do about pulmonary sarcoidosis Source: International Congress 2019 – State of the art session: Interstitial lung diseases Year: 2019 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The manifestations of rare organ sarcoidosis Source: Eur Respir Monogr 2022; 96: 295-315 Year: 2022 Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Sarcoidosis, a systemic disease Source: Annual Congress 2005 - Sarcoidosis: update on extrathoracic organ problems Year: 2005 Sarcoidosis Source: Respipedia Article Year: 2017 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Extrathoracic disease in sarcoidosis Source: Annual Congress 2009 - MP1 - Extrathoracic disease in sarcoidosis Year: 2009 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009 Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)? Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013